226 related articles for article (PubMed ID: 9725043)
1. [Characteristics of uterine cancer detected by mass screening].
Igarashi T; Konno R; Sato S; Yajima A
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1519-26. PubMed ID: 9725043
[TBL] [Abstract][Full Text] [Related]
2. [Case-control study of the effectiveness of mass screening in reducing invasive cervical cancer].
Makino H; Sato S; Yajima A; Fukao A
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Sep; 43(9):1226-32. PubMed ID: 1919184
[TBL] [Abstract][Full Text] [Related]
3. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
5. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
6. [The present status of mass population screening for cancer of the uterine cervix and the therapeutic results in the detected cases in Miyagi Prefecture].
Sato S; Toki T; Yamauchi R; Wakisaka T; Sakahira H; Mori T; Yajima A; Suzuki M; Nasu I; Sato S; Kaneda N; Higashiiwai H
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Feb; 35(2):127-33. PubMed ID: 6864010
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of the clinical features of uterine cervical cancers detected by mass screening and voluntary visit].
Yoh S; Hasuo Y; Tanaka H; Yakushizi M; Sakurai T
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1949-57. PubMed ID: 3382243
[TBL] [Abstract][Full Text] [Related]
8. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri.
Nieminen P; Kallio M; Hakama M
Obstet Gynecol; 1995 Jun; 85(6):1017-21. PubMed ID: 7770247
[TBL] [Abstract][Full Text] [Related]
9. Appropriate frequency of mass-screening for uterine cervical cancer.
Iwanari O
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Oct; 39(10):1799-805. PubMed ID: 3429977
[TBL] [Abstract][Full Text] [Related]
10. [Problem of uterine and ovarian cancer mass screening].
Ohmura M; Oda M
Gan To Kagaku Ryoho; 2002 Nov; 29(11):1907-16. PubMed ID: 12465389
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
12. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study.
Smith HO; Tiffany MF; Qualls CR; Key CR
Gynecol Oncol; 2000 Aug; 78(2):97-105. PubMed ID: 10926787
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
[TBL] [Abstract][Full Text] [Related]
14. Trends in cancer of the cervix uteri in Sweden following cytological screening.
Bergström R; Sparén P; Adami HO
Br J Cancer; 1999 Sep; 81(1):159-66. PubMed ID: 10487628
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of causes of increased incidence of cervical cancer in Slovenia.
Smrkolj S; Rakar S; Mozina A; Erzen M
Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):213-21. PubMed ID: 15541860
[TBL] [Abstract][Full Text] [Related]
16. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
[TBL] [Abstract][Full Text] [Related]
17. [Studies on the appropriate frequency of the cervical cancer screening (author's transl)].
Hando T; Kodama S; Obata N; Goto A; Takeuchi S; Aoki S
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Aug; 33(8):1205-8. PubMed ID: 7276648
[TBL] [Abstract][Full Text] [Related]
18. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
19. Uterine body cancer mass screening at Tokai University Hospital.
Nagase E; Yasuda M; Kajiwara H; Osamura RY; Yoshitake T; Hirasawa T; Muramatsu T; Miyamoto T; Murakami M; Makino T; Ogawa T
Tokai J Exp Clin Med; 2004 Jun; 29(2):43-8. PubMed ID: 15473339
[TBL] [Abstract][Full Text] [Related]
20. Comparisons of interval breast cancers with other breast cancers detected through mass screening and in outpatient clinics in Japan.
Yoshida K; Abe R; Itoh S; Taguchi T; Ohta J; Morimoto T; Ishida T; Tashiro H; Ogita M; Kido C
Jpn J Clin Oncol; 1990 Dec; 20(4):374-9. PubMed ID: 2283721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]